{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:53:24Z","timestamp":1773680004870,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.diagmicrobio.2006.11.015","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T07:04:44Z","timestamp":1171523084000},"page":"111-115","source":"Crossref","is-referenced-by-count":37,"title":["In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli isolated from urine and blood"],"prefix":"10.1016","volume":"58","author":[{"given":"Kwan","family":"Soo Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Yoeun Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyong","family":"Ran Peck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Young Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won","family":"Sup Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki","family":"Tae Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Sik Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam","family":"Yong Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum \u03b2-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0924-8579(00)00281-8","article-title":"Resistance of bacteria in urinary tract infections","volume":"16","author":"Chomarat","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib3","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. CLSI\/NCCLS Document M100-S15","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In vitro activity of fosfomycin against extended-spectrum-\u03b2-lactamase\u2013producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"de Cueto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2005.04.004","article-title":"Regional variation in the prevalence of extended-spectrum \u03b2-lactamase\u2013producing clinical isolates in the Asia-Pacific region (SENTRY 1998\u20132002)","volume":"52","author":"Hirakata","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2006.11.015_bib6","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0924-8579(03)00234-6","article-title":"Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus","volume":"22","author":"Hoepelman","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2006.11.015_bib7","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0924-8579(03)00238-3","article-title":"Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection","author":"Hooton","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib8","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1128\/JCM.42.7.2902-2906.2004","article-title":"Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey","volume":"42","author":"Jeong","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/dkg028","article-title":"An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project","volume":"51","author":"Kahlmeter","year":"2003","journal-title":"J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-0711-3-7","article-title":"Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002","volume":"3","author":"Karlowsky","year":"2004","journal-title":"Ann. Clin. Microbiol. Antimicrobiol."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.femsle.2005.02.029","article-title":"CTX-M and SHV-12 \u03b2-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea","volume":"245","author":"Kim","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1086\/381549","article-title":"Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989\u20132000 differences in the emergence and epidemiology of resistance across organisms","volume":"38","author":"Lautenbach","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/432940","article-title":"Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy","volume":"41","author":"Lautenbach","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/503046","article-title":"Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative","volume":"194","author":"Lautenbach","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib15","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.ijantimicag.2004.02.012","article-title":"Antimicrobial susceptibility of uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2002","volume":"24S","author":"Lee","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1473-3099(05)70166-3","article-title":"Minimizing antibiotic resistance","volume":"5","author":"Livermore","year":"2005","journal-title":"Lancet Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2006.11.015_bib17","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0924-8579(03)00230-9","article-title":"In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance","volume":"22","author":"Marchese","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2006.11.015_bib18","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.ijantimicag.2006.05.019","article-title":"Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections","volume":"28","author":"Mazzei","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib19","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","article-title":"Biological costs and mechanisms for fosfomycin resistance in Escherichia coli","volume":"47","author":"Nilsson","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3201\/eid1104.040699","article-title":"Antimicrobial-resistant invasive Escherichia coli, Spain","volume":"11","author":"Oteo","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib21","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jac\/dki324","article-title":"Dissemination of SHV-12 and CTX-M\u2013type extended-spectrum \u03b2-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea","volume":"56","author":"Ryoo","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2006.11.015_bib22","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0924-8579(03)00231-0","article-title":"Why fosfomycin trometamol as first line therapy for uncomplicated UTI?","volume":"22","author":"Schito","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2006.11.015_bib23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women","volume":"29","author":"Warren","year":"1999","journal-title":"Clin. Infect. Dis."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306004706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306004706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T03:24:26Z","timestamp":1547004266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889306004706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0732889306004706"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2006.11.015","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}